Navigation Links
Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects
Date:11/20/2008

RIVERSIDE, Calif., Nov. 20 /PRNewswire/ -- Milk. It does a body good. And now it's doing it even better than originally thought. After years of research, scientists at OncoNutrition(TM) have discovered peptides found in cow's milk that stimulate the body's own production of antioxidants.


    To view the Multimedia News Release, go to:
http://www.prnewswire.com/mnr/eqwestgroup/36121/

While developing new cancer therapies, the chief scientist, Dr. David Tsai, discovered that these peptides, once unlocked from their larger host protein, stimulate the production of the antioxidant enzyme Super Oxide Dismutase (SOD). When SOD was first discovered in 1968, it was dubbed 'the enzyme of life,' because it's the first antioxidant mobilized by the cell for defense. Cancer sufferers, especially those undergoing chemotherapy, often have high levels of free radicals, which deplete the body of antioxidants. As a result, vital organs can be overburdened and injured due to chemotherapy treatment. With AminoAct(TM), now available through OncoNutrition(TM), chemotherapy patients have access to a functional nutritional supplement that boosts their antioxidant levels and aids recovery from the damages of chemotherapy.

Cancer Treatment Review recently published a clinical review of 19 different studies indicating that antioxidant supplements taken by cancer patients resulted in increased survival time and increased treatment response. Antioxidants mainly come from two sources, either from nutrients like Vitamin C, or through antioxidant enzymes produced by the body. "AminoAct(TM) stimulates the body to produce its own antioxidants. Because our product works from the inside out, users benefit from a dramatic increase in their antioxidant levels," stated Olof Mollstedt, OncoNutrition's CEO.

"Our studies show that AminoAct(TM) increases the antioxidant levels in blood by over 200 percent in a seven-day period, while nutrient-based antioxidants only increase levels marginally." Mr. Mollstedt continued, "Antioxidants act as a shield for healthy cells, while allowing chemotherapy to battle cancerous cells. AminoAct(TM) greatly increases the size of that shield."

Because chemotherapy attacks not only cancer cells, but all cells, oftentimes cancer patients must stop treatment due to chemotherapy side effects. However, like antibiotics, chemotherapy is most effective when given in complete cycles. "By dramatically increasing antioxidant levels, AminoAct(TM) helps patients to stay on their chemotherapy regimens, thus increasing the overall treatment impact," stated Dr. Tsai.

In addition to stimulating SOD production, AminoAct(TM) also increases the secretion of ghrelin, a stomach hormone that stimulates appetite. According to the American Cancer Society, weight loss in the main cause of death for 1 in 5 cancer patients. "Our research was focused on eradicating cancer by allowing chemotherapy to do the job it's intended to do," Dr. Tsai said. "Knowing that cancer patients often succumb to death due to weight loss, when we uncovered that AminoAct(TM) also increases ghrelin production, we were elated."

The milk-based peptides in AminoAct(TM) are unlocked through a proprietary technology, and do not have adverse effects on those who are lactose intolerant. For more information, visit www.onconutrition.com, or call 951- 231-2388.

    Media Contacts:
    Chris French
    714-710-9229; 714-225-6142-C
    cfrench@eqwestgroup.com

    Helen Chen
    951-231-2106
    helenc@onconutrition.com

'/>"/>
SOURCE OncoNutrition
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Photos: SOS Childrens Villages Observes World Orphan Week, October 5-11, 2008
2. Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children
3. Photos: Sentara Joins 4 U.S. Hospitals in International TARGIT Breast Cancer Trial
4. Are Muramyl Peptides the Magic Bullet in Probiotics?
5. Tainted Chinese Food Ingredients First Discovered in 2005
6. Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain
7. Recent Data Study Suggests Cortisol Could Help Alleviate Suffering for Those With Chronic Fatigue Syndrome and Fibromyalgia
8. Zevalin(R) Following Short-Course Chemotherapy with CHOP + Rituximab (CHOP-R) Doubles Complete Remission Rate in First-Line Treatment of Follicular Non- Hodgkins Lymphoma
9. Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
10. Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium
11. Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
(Date:6/24/2016)... ... 24, 2016 , ... National recruitment firm Slone Partners is pleased ... and genomics experience, as Vice President of North American Capital Sales at HTG ... leading the sales team in the commercialization of the HTG EdgeSeq system and associated ...
Breaking Medicine News(10 mins):